{"PubmedArticle": [{"MedlineCitation": {"CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "InvestigatorList": [], "OtherID": [], "OtherAbstract": [], "SpaceFlightMission": [], "PMID": "5969585", "DateCompleted": {"Year": "1967", "Month": "09", "Day": "02"}, "DateRevised": {"Year": "2019", "Month": "11", "Day": "11"}, "Article": {"Language": ["ger"], "ELocationID": [], "ArticleDate": [], "Journal": {"JournalIssue": {"Volume": "208", "Issue": "4", "PubDate": {"Year": "1966"}}, "Title": "Archiv fur Psychiatrie und Nervenkrankheiten", "ISOAbbreviation": "Arch Psychiatr Nervenkr (1970)"}, "ArticleTitle": "[On the question of possible irreversible disorders due to psychopharmacotherapy].", "Pagination": {"StartPage": "345", "EndPage": "359", "MedlinePgn": "345-59"}, "AuthorList": [{"AffiliationInfo": [], "Identifier": [], "LastName": "Meyer", "ForeName": "H H", "Initials": "HH"}], "PublicationTypeList": ["Case Reports", "Journal Article"], "VernacularTitle": "Zur Frage m\u00f6glicherweise irreversibler St\u00f6rungen bei Psychopharmakotherapie."}, "MedlineJournalInfo": {"Country": "Germany", "MedlineTA": "Arch Psychiatr Nervenkr (1970)", "NlmUniqueID": "1270313"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Butyrophenones"}, {"RegistryNumber": "0", "NameOfSubstance": "Phenothiazines"}, {"RegistryNumber": "0", "NameOfSubstance": "Tranquilizing Agents"}, {"RegistryNumber": "0FRP6G56LD", "NameOfSubstance": "Biperiden"}, {"RegistryNumber": "6RC5V8B7PO", "NameOfSubstance": "Trihexyphenidyl"}, {"RegistryNumber": "FF28EJQ494", "NameOfSubstance": "Promethazine"}, {"RegistryNumber": "U42B7VYA4P", "NameOfSubstance": "Chlorpromazine"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": ["drug effects"], "DescriptorName": "Autonomic Nervous System"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Biperiden"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Butyrophenones"}, {"QualifierName": ["drug effects"], "DescriptorName": "Central Nervous System"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Chlorpromazine"}, {"QualifierName": [], "DescriptorName": "Extrapyramidal Tracts"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["chemically induced"], "DescriptorName": "Movement Disorders"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Phenothiazines"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Promethazine"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Psychotic Disorders"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Rauwolfia"}, {"QualifierName": ["adverse effects", "therapeutic use"], "DescriptorName": "Tranquilizing Agents"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Trihexyphenidyl"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Munch Med Wochenschr. 1965 Dec 3;107(49):2493-7", "ArticleIdList": ["5899623"]}, {"Citation": "Wien Z Nervenheilkd Grenzgeb. 1966;23(1):140-6", "ArticleIdList": ["4226879"]}, {"Citation": "Lancet. 1965 Feb 27;1(7383):458-60", "ArticleIdList": ["14241885"]}, {"Citation": "Arzneimittelforschung. 1966 Feb;16(2):276-9", "ArticleIdList": ["4861657"]}, {"Citation": "Nervenarzt. 1957 Mar 20;28(3):97-100", "ArticleIdList": ["13430888"]}, {"Citation": "Psychiatr Neurol (Basel). 1960 Aug;140:249-57", "ArticleIdList": ["13709207"]}, {"Citation": "Am J Psychiatry. 1960 Aug;117:152-3", "ArticleIdList": ["14412282"]}], "ReferenceList": []}], "History": [{"Year": "1966", "Month": "1", "Day": "1"}, {"Year": "1966", "Month": "1", "Day": "1", "Hour": "0", "Minute": "1"}, {"Year": "1966", "Month": "1", "Day": "1", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["5969585", "10.1007/BF00343050"]}}], "PubmedBookArticle": []}